PERJETA

Formula & Concentration

PERJETA – pertuzumab 420 mg/14 mL (30 mg/mL) intravenous solution

Manufacturer

Genentech Inc

Indications

HER2-positive carcinoma of breast

Product Options

Package Size

NDC #

Presentation

420 MG/14 ML

50242-0145-01

VIAL

Shelf Life and Storage

Fridge (2-8°C)